Sex-dependent grades of haematopoietic modulation in patients with major depressive episodes are associated with suicide attempts.


Journal

European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology
ISSN: 1873-7862
Titre abrégé: Eur Neuropsychopharmacol
Pays: Netherlands
ID NLM: 9111390

Informations de publication

Date de publication:
11 2020
Historique:
received: 19 12 2019
revised: 08 05 2020
accepted: 09 06 2020
pubmed: 1 7 2020
medline: 24 9 2021
entrez: 1 7 2020
Statut: ppublish

Résumé

Suicide is the leading cause of non-natural death worldwide, and major depressive disorder (MDD) is the mood disorder with the highest prevalence among individuals with suicidal behaviour (SB). The role of inflammation and immunomodulation in mood disorders has raised interest in recent years, as inflammation biomarkers have been reported to be increased in mood disorder patients, suggesting a role of inflammation in their pathogenesis. The influence of inflammation on the haematopoietic production is well known; however, a comprehensive study of the haematopoietic production in patients with major depressive episodes (MDE) is lacking. We examined global haematopoietic parameters from complete blood counts (CBC) of patients with MDE, in search of prognostic patterns. MDE patients presented differences in several CBC parameters, differences that were clearly pronounced and/or significant in concurrence with suicide attempts (SA). Red and white blood cell lineage parameters were affected, suggesting general haematopoietic modulation or imbalance. We observed distinct haematological parameter changes in women versus men, with men presenting milder alterations than women. Interestingly, we found that the List of Threatening Experiences (LTE) score, but not the Childhood Trauma Questionnaire (CTQ), was associated with the haematopoietic alterations observed exclusively in women and, more importantly, served as a parameter to stratify female MDE patients based on concurrence or non-concurrence with SA. In conclusion, grades of haematopoietic modulation in MDE patients are associated with absence or presence of SA. Haematopoietic manifestations differ between men and women and, in the latter, are markedly influenced by late, and not early, traumatic events.

Identifiants

pubmed: 32600963
pii: S0924-977X(20)30192-9
doi: 10.1016/j.euroneuro.2020.06.006
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

17-30

Informations de copyright

Copyright © 2020 The Author(s). Published by Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Conflict of interest All authors declare no conflict of interest relative to this study.

Auteurs

Patricia Martínez-Botía (P)

Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Oviedo, Spain; Department of Medicine, Universidad de Oviedo, Spain.

Angela Velasco (A)

Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Oviedo, Spain; Department of Psychiatry, Universidad de Oviedo, Spain; Biomedical Research Networking Centre in Mental Health (CIBERSAM), Oviedo, Spain.

Valeria Rolle (V)

Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Oviedo, Spain.

Luis Jiménez-Trevino (L)

Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Oviedo, Spain; Department of Psychiatry, Universidad de Oviedo, Spain; Biomedical Research Networking Centre in Mental Health (CIBERSAM), Oviedo, Spain; Servicio de Salud del Principado de Asturias (SESPA), Oviedo, Spain.

Lorena De la Fuente-Tomás (L)

Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Oviedo, Spain; Department of Psychiatry, Universidad de Oviedo, Spain; Biomedical Research Networking Centre in Mental Health (CIBERSAM), Oviedo, Spain.

Ángel Bernardo (Á)

Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Oviedo, Spain; Hospital Universitario Central de Asturias, Laboratorio de Diagnóstico Clínico Hematología, Oviedo, Spain.

Tamara Arias (T)

Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Oviedo, Spain; Centro Comunitario de Sangre y Tejidos de Asturias, Oviedo, Spain.

María Del Carmen Muñoz-Turrillas (MDC)

Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Oviedo, Spain; Centro Comunitario de Sangre y Tejidos de Asturias, Oviedo, Spain.

Leticia García-Alvarez (L)

Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Oviedo, Spain; Biomedical Research Networking Centre in Mental Health (CIBERSAM), Oviedo, Spain.

Leticia González-Blanco (L)

Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Oviedo, Spain; Department of Psychiatry, Universidad de Oviedo, Spain; Biomedical Research Networking Centre in Mental Health (CIBERSAM), Oviedo, Spain; Servicio de Salud del Principado de Asturias (SESPA), Oviedo, Spain.

Julia Rodríguez-Revuelta (J)

Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Oviedo, Spain; Department of Psychiatry, Universidad de Oviedo, Spain; Servicio de Salud del Principado de Asturias (SESPA), Oviedo, Spain.

Maria Paz Garcia-Portilla (MP)

Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Oviedo, Spain; Department of Psychiatry, Universidad de Oviedo, Spain; Biomedical Research Networking Centre in Mental Health (CIBERSAM), Oviedo, Spain; Servicio de Salud del Principado de Asturias (SESPA), Oviedo, Spain.

Philippe Courtet (P)

Department of Emergency Psychiatry & Post-Acute Care, Lapeyronie Hospital, CHU Montpellier - Inserm U1061, University of Montpellier, Montpellier, France; Fondation FondaMental, Créteil, France.

Julio Bobes (J)

Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Oviedo, Spain; Department of Psychiatry, Universidad de Oviedo, Spain; Biomedical Research Networking Centre in Mental Health (CIBERSAM), Oviedo, Spain; Servicio de Salud del Principado de Asturias (SESPA), Oviedo, Spain.

Laura Gutiérrez (L)

Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Oviedo, Spain; Department of Medicine, Universidad de Oviedo, Spain. Electronic address: gutierrezglaura@uniovi.es.

Pilar Alejandra Sáiz (PA)

Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Oviedo, Spain; Department of Psychiatry, Universidad de Oviedo, Spain; Biomedical Research Networking Centre in Mental Health (CIBERSAM), Oviedo, Spain; Servicio de Salud del Principado de Asturias (SESPA), Oviedo, Spain. Electronic address: frank@uniovi.es.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH